Press Releases

Press Releases

January 14, 2016
Platine Pharma Services SAS (PPS), a majority owned subsidiary of ABL, Inc., is a preferred partner with Quanterix Corporation, providing new ultrasensitive assays using the single molecule measurement digital platform, Simoa.
January 11, 2016
Quanterix announces that it will be presenting at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California.    
December 2, 2015
Quanterix announces the success of the company’s recent user conference entitled, “Proteins Powering NextGen Healthcare: San Francisco.”
LEXINGTON, MA – November 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that the paper, “
LEXINGTON, MA – October 28, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the launch of Simoa 2.0, its next-generation ultrasensitive immunoassay platform. Simoa 2.0…
LEXINGTON, MA – October 20, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it is hosting its second bi-annual conference, entitled, “Proteins Powering NexGen Healthcare…
LEXINGTON, MA – October 6, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the publication of a collaborative whitepaper that addresses concussion management, science, policy…
LEXINGTON, MA – August 26, 2015 Quanterix Corporation, a leader in high definition diagnostics, today announced that The Journal of Clinical Chemistry has published a new study in which its single molecule array technology (Simoa) was used to measure cardiac troponin I (cTnI) levels with both high…
LEXINGTON, MA – August 5, 2015 Quanterix Corporation, a leader in high definition diagnostics, today announced that the Journal of Clinical Microbiology has published a new study in which its Simoa (single molecule array) technology was used to develop a rapid, simple tool to allow diagnosis of…
LEXINGTON, MA – August 3, 2015 Quanterix Corporation, a leader in high definition diagnostics, today announced that JAMA Neurology has published a new study in which its Simoa (single molecule array) technology was used to identify a protein previously linked to acute symptoms following a traumatic…